Patient presents with symptoms suggestive of small cell lung cancer (SCLC), including persistent cough, hemoptysis, dyspnea, and chest pain.  On physical examination, findings may include diminished breath sounds, wheezing, or lymphadenopathy.  The patient reports a significant smoking history of [number] pack-years.  Imaging studies, including chest x-ray and CT scan of the chest, abdomen, and pelvis, reveal a [description of findings, e.g., hilar mass, mediastinal lymphadenopathy, possible metastatic lesions].  Bronchoscopy with biopsy was performed, and histopathological analysis confirmed the diagnosis of small cell carcinoma.  Immunohistochemistry staining is positive for [specify markers, e.g., chromogranin, synaptophysin, CD56].  Staging workup, including bone scan and brain MRI, is underway to determine the extent of disease.  The patient's performance status is assessed using the Eastern Cooperative Oncology Group (ECOG) scale as [ECOG score].  Based on the clinical presentation, imaging findings, and histopathology, the diagnosis of small cell lung cancer, limited stage vs. extensive stage (pending staging results), is established.  The patient was counseled regarding treatment options, including chemotherapy, radiation therapy, and potential clinical trials.  A multidisciplinary approach involving medical oncology, radiation oncology, and pulmonology is planned.  Patient education regarding prognosis, palliative care options, and smoking cessation was provided.  Follow-up appointment scheduled for [date] to discuss treatment plan and staging results.  ICD-10 code C34.90, Lung cancer, unspecified, is used for initial documentation, pending further staging.  Medical billing codes will be updated based on treatment plan.